Showing results (1261-1270 of 1,512) with videos related to

Sort By:
Pageof 152
Cancer Research and Treatment|May 19, 2016
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant GliomaYongjun Cha, Yu Jung Kim, Se-Hoon Lee, et al.
Orthodontics & Craniofacial Research|December 3, 2024
CBCT Analysis of the Hyoid and Pharyngeal Airway Changes in Class III Patients With Orthognathic SurgerySi-Mai Chen, Hua-Yang Cai, Xing-Zhi Yan, et al.
Surgery|June 12, 2012
Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinomaJae-Lyun Lee, Song Cheol Kim, Ji-Hoon Kim, et al.
Annals of Neurology|August 2, 2023
Clonal Hematopoiesis and Acute Ischemic Stroke OutcomesEung-Joon Lee, Hong Yul An, Jiwoo Lim, et al.
BJU International|August 14, 2013
Trends in renal function after radical nephrectomy: a multicentre analysisJae S Chung, Nak H Son, Seok-Soo Byun, et al.
Scientific Reports|February 18, 2017
Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic CholangiocarcinomaKwangwoo Nam, Dae Wook Hwang, Ju Hyun Shim, et al.
Gastrointestinal Endoscopy|April 24, 2003
Ectopic opening of the common bile duct in the duodenal bulb: clinical implicationsSang Soo Lee, Myung-Hwan Kim, Sung-Koo Lee, et al.
Cancer Investigation|February 9, 2008
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancerYu Jung Kim, Min A Kim, Seock-Ah Im, et al.
Cancer Research and Treatment|February 13, 2014
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by ChemotherapyHee Yeon Lee, Hoon-Kyo Kim, Kyung Hee Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2024
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancerSiyeon Park, Seongyeol Park, Tae Min Kim, et al.
Pageof 152